DADC
ELGX

D.A. Davidson & Co’s Endologix Inc ELGX Stock Holding History

D.A. Davidson & Co’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100
Closed -$4K – 2259
2017
Q2 		$4K Hold
100
– – ﹤0.01% 2252
2017
Q1 		$7K Hold
100
– – ﹤0.01% 2122
2016
Q4 		$5K Hold
100
– – ﹤0.01% 2270
2016
Q3 		$12K Buy
+100
New +$12.8K ﹤0.01% 2008

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

D.A. Davidson & Co's ELGX Position: Q3 2017 in Review

D.A. Davidson & Co sold out of Endologix Inc (ELGX) in Q3 2017, closing a stake of 100 shares — an estimated $4K sold.

D.A. Davidson & Co first reported a position in ELGX in Q3 2016 and held it in 4 quarters. The position peaked at $12K in Q3 2016. 106 funds tracked by Wall St. Rank hold ELGX as of Q3 2017.

  • D.A. Davidson & Co reported no remaining Endologix Inc position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 100 Endologix Inc shares in Q3 2017, an estimated $4K.
  • D.A. Davidson & Co first reported a position in Endologix Inc in Q3 2016 and held it in 4 quarters.
  • D.A. Davidson & Co's Endologix Inc position peaked at $12K in Q3 2016.
  • 106 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.